{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:17:46Z","timestamp":1792531066888,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2011,7,21]],"date-time":"2011-07-21T00:00:00Z","timestamp":1311206400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s00262-011-1071-x","type":"journal-article","created":{"date-parts":[[2011,7,20]],"date-time":"2011-07-20T10:17:47Z","timestamp":1311157067000},"page":"1729-1738","source":"Crossref","is-referenced-by-count":200,"title":["Prognostic impact of B-cell density in cutaneous melanoma"],"prefix":"10.1007","volume":"60","author":[{"given":"Andrea","family":"Lad\u00e1nyi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Mohos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Be\u00e1ta","family":"Somlai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Liszkay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Gilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsanna","family":"Fej\u0151s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n","family":"Gaudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"Dobos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f3zsef","family":"T\u00edm\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,7,21]]},"reference":[{"key":"1071_CR1","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/0959-8049(94)E0159-2","volume":"30A","author":"S Vesalainen","year":"1994","unstructured":"Vesalainen S, Lipponen P, Talja M, Syrjanen K (1994) Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma. Eur J Cancer 30A:1797\u20131803","journal-title":"Eur J Cancer"},{"key":"1071_CR2","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/bjc.1996.434","volume":"74","author":"LP Set\u00e4l\u00e4","year":"1996","unstructured":"Set\u00e4l\u00e4 LP, Kosma VM, Marin S, Lipponen PK, Eskelinen MJ, Syrjanen KJ, Alhava EM (1996) Prognostic factors in gastric cancer: the value of vascular invasion, mitotic rate and lymphoplasmacytic infiltration. Br J Cancer 74:766\u2013772","journal-title":"Br J Cancer"},{"key":"1071_CR3","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.1129139","volume":"313","author":"J Galon","year":"2006","unstructured":"Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pag\u00e8s C, Tosolini M, Camus M, Berger A, Wind P, Zinzindohu\u00e9 F, Bruneval P, Cugnenc P-H, Trajanoski Z, Fridman W-H, Pag\u00e8s F (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313:1960\u20131964","journal-title":"Science"},{"key":"1071_CR4","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1158\/1078-0432.CCR-08-0133","volume":"14","author":"KI Al-Shibli","year":"2008","unstructured":"Al-Shibli KI, Donnem T, Al-Saad S, Persson M, Bremnes RM, Busund L-T (2008) Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer. Clin Cancer Res 14:5220\u20135227","journal-title":"Clin Cancer Res"},{"key":"1071_CR5","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1038\/sj.bjc.6604738","volume":"99","author":"HE Lee","year":"2008","unstructured":"Lee HE, Chae SW, Lee YJ, Kim MA, Lee HS, Lee BL, Kim WH (2008) Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer. Br J Cancer 99:1704\u20131711","journal-title":"Br J Cancer"},{"key":"1071_CR6","first-page":"3491","volume":"58","author":"Y Naito","year":"1998","unstructured":"Naito Y, Saito K, Shiiba K, Ohuchi A, Saigenji K, Nagura H, Ohtani H (1998) CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res 58:3491\u20133494","journal-title":"Cancer Res"},{"key":"1071_CR7","doi-asserted-by":"crossref","first-page":"18538","DOI":"10.1073\/pnas.0509182102","volume":"102","author":"E Sato","year":"2005","unstructured":"Sato E, Olson SH, Ahn J, Bundy B, Nishikawa H, Qian F, Jungbluth AA, Frosina D, Gnjatic S, Ambrosone C, Kepner J, Odunsi T, Ritter G, Lele S, Chen Y-T, Ohtani H, Old LJ, Odunsi K (2005) Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+\/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci USA 102:18538\u201318543","journal-title":"Proc Natl Acad Sci USA"},{"key":"1071_CR8","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1093\/jnci\/81.24.1893","volume":"81","author":"WH Clark Jr","year":"1989","unstructured":"Clark WH Jr, Elder DE, Guerry D IV, Braitman LE, Trock BJ, Schultz D, Synnestvedt M, Halpern AC (1989) Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 81:1893\u20131904","journal-title":"J Natl Cancer Inst"},{"key":"1071_CR9","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5","volume":"77","author":"CG Clemente","year":"1996","unstructured":"Clemente CG, Mihm MC Jr, Bufalino R, Zurrida S, Collini P, Cascinelli N (1996) Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer 77:1303\u20131310","journal-title":"Cancer"},{"key":"1071_CR10","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/(SICI)1097-0142(19960801)78:3<427::AID-CNCR8>3.0.CO;2-G","volume":"78","author":"RL Barnhill","year":"1996","unstructured":"Barnhill RL, Fine JA, Roush GC, Berwick M (1996) Predicting five-year outcome for patients with cutaneous melanoma in a population-based study. Cancer 78:427\u2013432","journal-title":"Cancer"},{"key":"1071_CR11","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1200\/JCO.2006.08.9755","volume":"25","author":"RC Taylor","year":"2007","unstructured":"Taylor RC, Patel A, Panageas KS, Busam KJ, Brady MS (2007) Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma. J Clin Oncol 25:869\u2013875","journal-title":"J Clin Oncol"},{"key":"1071_CR12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00262-007-0353-9","volume":"57","author":"F Hillen","year":"2008","unstructured":"Hillen F, Beaten CIM, van de Winkel A, Creytens D, van der Schaft DWJ, Winnepenninckx V, Griffioen AW (2008) Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma. Cancer Immunol Immunother 57:97\u2013106","journal-title":"Cancer Immunol Immunother"},{"key":"1071_CR13","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/1097-0142(197710)40:4<1365::AID-CNCR2820400402>3.0.CO;2-N","volume":"40","author":"RL Ridolfi","year":"1977","unstructured":"Ridolfi RL, Rosen PP, Port A, Kinne D, Mik\u00e9 V (1977) Medullary carcinoma of the breast: a clinicopathologic study with 10\u00a0year follow-up. Cancer 40:1365\u20131385","journal-title":"Cancer"},{"key":"1071_CR14","first-page":"2603","volume":"34","author":"JC Whelchel","year":"1993","unstructured":"Whelchel JC, Farah SE, McLean IW, Burnier MN (1993) Immunohistochemistry of infiltrating lymphocytes in uveal malignant melanoma. Invest Ophthalmol Vis Sci 34:2603\u20132606","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1071_CR15","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00262-003-0409-4","volume":"52","author":"JA Coronella-Wood","year":"2003","unstructured":"Coronella-Wood JA, Hersh EM (2003) Naturally occurring B-cell responses to breast cancer. Cancer Immunol Immunother 52:715\u2013738","journal-title":"Cancer Immunol Immunother"},{"key":"1071_CR16","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.4049\/jimmunol.1001323","volume":"185","author":"BH Nelson","year":"2010","unstructured":"Nelson BH (2010) CD20+ B cells: the other tumor-infiltrating lymphocytes. J Immunol 185:4977\u20134982","journal-title":"J Immunol"},{"key":"1071_CR17","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3109\/00313028509105490","volume":"17","author":"P Hersey","year":"1985","unstructured":"Hersey P, Murray E, Grace J, McCarthy WH (1985) Current research on immunopathology of melanoma: analysis of lymphocyte populations in relation to antigen expression and histological features of melanoma. Pathology 17:385\u2013391","journal-title":"Pathology"},{"key":"1071_CR18","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/BF00711292","volume":"410","author":"E Ralfkaier","year":"1987","unstructured":"Ralfkaier E, Hou-Jensen K, Gatter KC, Drzewiecki KT, Mason DY (1987) Immunohistological analysis of the lymphoid infiltrate in cutaneous malignant melanomas. Virchow Arch A 410:355\u2013361","journal-title":"Virchow Arch A"},{"key":"1071_CR19","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/jcp.2005.028860","volume":"59","author":"MR Hussein","year":"2006","unstructured":"Hussein MR, Elsers DAH, Fadel SA, Omar A-EM (2006) Immunohistological characterization of tumour infiltrating lymphocytes in melanocytic skin lesions. J Clin Pathol 59:316\u2013324","journal-title":"J Clin Pathol"},{"key":"1071_CR20","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1158\/1078-0432.CCR-1161-03","volume":"10","author":"A Lad\u00e1nyi","year":"2004","unstructured":"Lad\u00e1nyi A, Somlai B, Gilde K, Fej\u00f6s Z, Gaudi I, T\u00edm\u00e1r J (2004) T-cell activation marker expression on tumor-infiltrating lymphocytes as prognostic factor in cutaneous malignant melanoma. Clin Cancer Res 10:521\u2013530","journal-title":"Clin Cancer Res"},{"key":"1071_CR21","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s00262-007-0286-3","volume":"56","author":"A Lad\u00e1nyi","year":"2007","unstructured":"Lad\u00e1nyi A, Kiss J, Somlai B, Gilde K, Fej\u0151s Z, Mohos A, Gaudi I, T\u00edm\u00e1r J (2007) Density of DC-LAMP+ mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor. Cancer Immunol Immunother 56:1459\u20131469","journal-title":"Cancer Immunol Immunother"},{"key":"1071_CR22","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1200\/JCO.2001.19.16.3635","volume":"19","author":"CM Balch","year":"2001","unstructured":"Balch CM, Buzaid AC, Soong S-J, Atkins MB, Cascinelli N, Coit DG, Fleming ID, Gershenwald JE, Houghton A Jr, Kirkwood JM, McMasters KM, Mihm MF, Morton DL, Reintgen DS, Ross MI, Sober A, Thompson JA, Thompson JF (2001) Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 19:3635\u20133648","journal-title":"J Clin Oncol"},{"key":"1071_CR23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF02893437","volume":"13","author":"J Kiss","year":"2007","unstructured":"Kiss J, T\u00edm\u00e1r J, Somlai B, Gilde K, Fej\u0151s Z, Gaudi I, Lad\u00e1nyi A (2007) Association of microvessel density with infiltrating cells in human cutaneous malignant melanoma. Pathol Oncol Res 13:21\u201331","journal-title":"Pathol Oncol Res"},{"key":"1071_CR24","doi-asserted-by":"crossref","first-page":"12659","DOI":"10.1073\/pnas.171460798","volume":"98","author":"MH Hansen","year":"2001","unstructured":"Hansen MH, Nielsen H, Ditzel HJ (2001) The tumor-infiltrating B cell response in medullary breast cancer is oligoclonal and directed against the autoantigen actin exposed on the surface of apoptotic cancer cells. Proc Natl Acad Sci USA 98:12659\u201312664","journal-title":"Proc Natl Acad Sci USA"},{"key":"1071_CR25","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00262-001-0234-6","volume":"50","author":"PM O\u2019Brien","year":"2001","unstructured":"O\u2019Brien PM, Tsirimonaki E, Coomber DW, Millan DW, Davis JA, Campo MS (2001) Immunoglobulin genes expressed by B-lymphocytes infiltrating cervical carcinoma show evidence of antigen-driven selection. Cancer Immunol Immunother 50:523\u2013532","journal-title":"Cancer Immunol Immunother"},{"key":"1071_CR26","first-page":"7889","volume":"61","author":"JA Coronella","year":"2001","unstructured":"Coronella JA, Tellemann P, Kingsbury GA, Truong TD, Hays S, Junghans RP (2001) Evidence for an antigen-driven humoral immune response in medullary ductal breast cancer. Cancer Res 61:7889\u20137899","journal-title":"Cancer Res"},{"key":"1071_CR27","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.4049\/jimmunol.169.4.1829","volume":"169","author":"JA Coronella","year":"2002","unstructured":"Coronella JA, Spier C, Welch M, Trevor KT, Stopeck AT, Villar H, Hersh EM (2002) Antigen-driven oligoclonal expansion of tumor-infiltrating B cells in infiltrating ductal carcinoma of the breast. J Immunol 169:1829\u20131836","journal-title":"J Immunol"},{"key":"1071_CR28","first-page":"3275","volume":"63","author":"S Nzula","year":"2003","unstructured":"Nzula S, Going JJ, Stott DI (2003) Antigen-driven clonal proliferation, somatic hypermutation, and selection of B lymphocytes infiltrating human ductal breast carcinomas. Cancer Res 63:3275\u20133280","journal-title":"Cancer Res"},{"key":"1071_CR29","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/ijc.2910520623","volume":"52","author":"NM Yeilding","year":"1992","unstructured":"Yeilding NM, Gerstner C, Kirkwood JM (1992) Analysis of two human monoclonal antibodies against melanoma. Int J Cancer 52:967\u2013973","journal-title":"Int J Cancer"},{"key":"1071_CR30","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF01533513","volume":"38","author":"CJA Punt","year":"1994","unstructured":"Punt CJA, Barbuto JAM, Zhang H, Grimes WJ, Hatch KD, Hersh EM (1994) Anti-tumor antibody produced by human tumor-infiltrating and peripheral blood B lymphocytes. Cancer Immunol Immunother 38:225\u2013232","journal-title":"Cancer Immunol Immunother"},{"key":"1071_CR31","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.4049\/jimmunol.175.4.2278","volume":"175","author":"B Kotlan","year":"2005","unstructured":"Kotlan B, Simsa P, Teillaud J-L, Fridman WH, Toth J, McKnight M, Glassy MC (2005) Novel ganglioside antigen identified by B cells in human medullary breast carcinomas: the proof of principle concerning the tumor-infiltrating B lymphocytes. J Immunol 175:2278\u20132285","journal-title":"J Immunol"},{"key":"1071_CR32","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1200\/JCO.2007.15.0284","volume":"26","author":"M-C Dieu-Nosjean","year":"2008","unstructured":"Dieu-Nosjean M-C, Antoine M, Danel C, Heudes D, Wislez M, Poulot V, Rabbe N, Laurans L, Tartour E, de Chaisemartin L, Lebecque S, Fridman W-H, Cadranel J (2008) Long-term survival for patients with non\u2013small-cell lung cancer with intratumoral lymphoid structures. J Clin Oncol 26:4410\u20134417","journal-title":"J Clin Oncol"},{"key":"1071_CR33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/path.1018","volume":"196","author":"A Suzuki","year":"2002","unstructured":"Suzuki A, Masuda A, Nagata H, Kameoka S, Kikawada Y, Yamakawa M, Kasajima T (2002) Mature dendritic cells make clusters with T cells in the invasive margin of colorectal carcinoma. J Pathol 196:37\u201343","journal-title":"J Pathol"},{"key":"1071_CR34","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ccr.2005.04.014","volume":"7","author":"KE de Visser","year":"2005","unstructured":"de Visser KE, Korets LV, Coussens LM (2005) De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 7:411\u2013423","journal-title":"Cancer Cell"},{"key":"1071_CR35","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4049\/jimmunol.121.1.359","volume":"121","author":"P Brodt","year":"1978","unstructured":"Brodt P, Gordon J (1978) Anti-tumor immunity in B lymphocyte-deprived mice. I. immunity to a chemically induced tumor. J Immunol 121:359\u2013362","journal-title":"J Immunol"},{"key":"1071_CR36","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nm0598-627","volume":"4","author":"Z Qin","year":"1998","unstructured":"Qin Z, Richter G, Sch\u00fcler T, Ibe S, Cao X, Blankenstein T (1998) B cells inhibit induction of T cell-dependent tumor immunity. Nat Med 4:627\u2013630","journal-title":"Nat Med"},{"key":"1071_CR37","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ijc.21177","volume":"117","author":"S Shah","year":"2005","unstructured":"Shah S, Divekar AA, Hilchey SP, Cho H-M, Newman CL, Shin S-U, Nechustan H, Challita-Eid PM, Segal BM, Yi KH (2005) Increased rejection of primary tumors in mice lacking B cells: inhibition of anti-tumor CTL and TH1 cytokine responses by B cells. Int J Cancer 117:574\u2013586","journal-title":"Int J Cancer"},{"key":"1071_CR38","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.2118273","volume":"249","author":"KR Schultz","year":"1990","unstructured":"Schultz KR, Klarnet JP, Gieni RS, HayGlass KT, Greenberg PD (1990) The role of B cells for in vivo T cell responses to a Friend virus-induced leukemia. Science 249:921\u2013923","journal-title":"Science"},{"key":"1071_CR39","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.4049\/jimmunol.0903009","volume":"184","author":"DJ DiLillo","year":"2010","unstructured":"DiLillo DJ, Yanaba K, Tedder TF (2010) B cells are required for optimal CD4+ and CD8+ T cell tumor immunity: therapeutic B cell depletion enhances B16 melanoma growth in mice. J Immunol 184:4006\u20134016","journal-title":"J Immunol"},{"key":"1071_CR40","first-page":"992","volume":"18","author":"N Kaliss","year":"1958","unstructured":"Kaliss N (1958) Immunological enhancement of tumor homografts in mice: a review. Cancer Res 18:992\u20131003","journal-title":"Cancer Res"},{"key":"1071_CR41","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-1-4613-9558-4_4","volume":"2","author":"FA Salinas","year":"1986","unstructured":"Salinas FA, Wee KH (1986) Prognostic and pathogenetic implications of immune complexes in human cancer. Adv Immun Cancer Ther 2:189\u2013209","journal-title":"Adv Immun Cancer Ther"},{"key":"1071_CR42","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-065X.2008.00600.x","volume":"222","author":"M Johansson","year":"2008","unstructured":"Johansson M, DeNardo DG, Coussens LM (2008) Polarized immune responses differentially regulate cancer development. Immunol Rev 222:145\u2013154","journal-title":"Immunol Rev"},{"key":"1071_CR43","first-page":"2836","volume":"63","author":"R Lapointe","year":"2003","unstructured":"Lapointe R, Bellemare-Pelletier A, Housseau F, Thibodeau J, Hwu P (2003) CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells. Cancer Res 63:2836\u20132843","journal-title":"Cancer Res"},{"key":"1071_CR44","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.4049\/jimmunol.175.3.1424","volume":"175","author":"Q Li","year":"2005","unstructured":"Li Q, Grover AC, Donald EJ, Carr A, Yu J, Whitfield J, Nelson M, Takeshita N, Chang AE (2005) Simultaneous targeting of CD3 on T cells and CD40 on B or dendritic cells augments the antitumor reactivity of tumor-primed lymph node cells. J Immunol 175:1424\u20131432","journal-title":"J Immunol"},{"key":"1071_CR45","doi-asserted-by":"crossref","first-page":"5558","DOI":"10.4049\/jimmunol.165.10.5558","volume":"165","author":"P-J Linton","year":"2000","unstructured":"Linton P-J, Harbertson J, Bradley LM (2000) A critical role for B cells in the development of memory CD4 cells. J Immunol 165:5558\u20135565","journal-title":"J Immunol"},{"key":"1071_CR46","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1093\/intimm\/13.12.1583","volume":"13","author":"A Rivera","year":"2001","unstructured":"Rivera A, Chen CC, Ron N, Dougherty JP, Ron Y (2001) Role of B cells as antigen-presenting cells in vivo revisited: antigen-specific B cells are essential for T cell expansion in lymph nodes and for systemic T cell responses to low antigen concentrations. Int Immunol 13:1583\u20131593","journal-title":"Int Immunol"},{"key":"1071_CR47","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1084\/jem.20021290","volume":"197","author":"P-J Linton","year":"2003","unstructured":"Linton P-J, Bautista B, Biederman E, Bradley ES, Harbertson J, Kondrack RM, Padrick RC, Bradley LM (2003) Costimulation via OX40L expressed by B cells is sufficient to determine the extent of primary CD4 cell expansion and Th2 cytokine secretion in vivo. J Exp Med 197:875\u2013883","journal-title":"J Exp Med"},{"key":"1071_CR48","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00262-009-0733-4","volume":"58","author":"M Reuschenbach","year":"2009","unstructured":"Reuschenbach M, von Knebel Doeberitz M, Wentzensen N (2009) A systematic review of humoral immune response against tumor antigens. Cancer Immunol Immunother 58:1535\u20131544","journal-title":"Cancer Immunol Immunother"},{"key":"1071_CR49","doi-asserted-by":"crossref","first-page":"e6412","DOI":"10.1371\/journal.pone.0006412","volume":"4","author":"K Milne","year":"2009","unstructured":"Milne K, K\u00f6bel M, Kalloger SE, Barnes RO, Gao D, Gilks CB, Watson PH, Nelson BH (2009) Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors. PLoS One 4:e6412","journal-title":"PLoS One"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-011-1071-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-011-1071-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-011-1071-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T06:32:14Z","timestamp":1686205934000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-011-1071-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,21]]},"references-count":49,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1071"],"URL":"https:\/\/doi.org\/10.1007\/s00262-011-1071-x","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,21]]}}}